-+ 0.00%
-+ 0.00%
-+ 0.00%

Envoy Medical says all 56 patients activate Acclaim cochlear implant in pivotal trial

PUBT·04/22/2026 12:09:25
Listen to the news
Envoy Medical says all 56 patients activate Acclaim cochlear implant in pivotal trial
  • Envoy Medical reported all 56 patients in its pivotal US trial of fully implanted Acclaim cochlear implant have completed initial activation visits.
  • Trial results have not been presented yet; Envoy expects to analyze data once 12-month follow-up is complete for all patients.
  • Company plans to submit findings to FDA as part of a Premarket Approval application.
  • Update firms up trial timeline, supporting visibility into regulatory milestones for investigational device targeting severe to profound hearing loss.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief on April 22, 2026, and is solely responsible for the information contained therein.